224 related articles for article (PubMed ID: 30287838)
1. Systematic expression alteration analysis of master reprogramming factor OCT4 and its three pseudogenes in human cancer and their prognostic outcomes.
Saha SK; Jeong Y; Cho S; Cho SG
Sci Rep; 2018 Oct; 8(1):14806. PubMed ID: 30287838
[TBL] [Abstract][Full Text] [Related]
2. Oct4 pseudogenes are transcribed in cancers.
Suo G; Han J; Wang X; Zhang J; Zhao Y; Zhao Y; Dai J
Biochem Biophys Res Commun; 2005 Dec; 337(4):1047-51. PubMed ID: 16229821
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of Oct4 variants and pseudogenes in normal urothelium and urothelial cancer.
Wezel F; Pearson J; Kirkwood LA; Southgate J
Am J Pathol; 2013 Oct; 183(4):1128-1136. PubMed ID: 23933063
[TBL] [Abstract][Full Text] [Related]
4. Differential Expression of OCT4 Pseudogenes in Pluripotent and Tumor Cell Lines.
Poursani EM; Mohammad Soltani B; Mowla SJ
Cell J; 2016; 18(1):28-36. PubMed ID: 27054116
[TBL] [Abstract][Full Text] [Related]
5. All the Tested Human Somatic Cells Express Both Oct4A and Its Pseudogenes but Express Oct4A at Much Lower Levels Compared with Its Pseudogenes and Human Embryonic Stem Cells.
Xu G; Yang L; Zhang W; Wei X
Stem Cells Dev; 2015 Jul; 24(13):1546-57. PubMed ID: 25687509
[TBL] [Abstract][Full Text] [Related]
6. Expression of OCT4 pseudogenes in human tumours: lessons from glioma and breast carcinoma.
Zhao S; Yuan Q; Hao H; Guo Y; Liu S; Zhang Y; Wang J; Liu H; Wang F; Liu K; Ling EA; Hao A
J Pathol; 2011 Apr; 223(5):672-82. PubMed ID: 21341266
[TBL] [Abstract][Full Text] [Related]
7. A novel variant of Oct3/4 gene in mouse embryonic stem cells.
Guo CL; Liu L; Jia YD; Zhao XY; Zhou Q; Wang L
Stem Cell Res; 2012 Sep; 9(2):69-76. PubMed ID: 22683460
[TBL] [Abstract][Full Text] [Related]
8. OCT4 spliced variants are highly expressed in brain cancer tissues and inhibition of OCT4B1 causes G2/M arrest in brain cancer cells.
Asadi MH; Khalifeh K; Mowla SJ
J Neurooncol; 2016 Dec; 130(3):455-463. PubMed ID: 27585657
[TBL] [Abstract][Full Text] [Related]
9. The novel OCT4 spliced variant OCT4B1 can generate three protein isoforms by alternative splicing into OCT4B.
Gao Y; Wang X; Han J; Xiao Z; Chen B; Su G; Dai J
J Genet Genomics; 2010 Jul; 37(7):461-5. PubMed ID: 20659710
[TBL] [Abstract][Full Text] [Related]
10. OCT4B2, a novel alternative spliced variant of OCT4, is significantly upregulated under heat-stress condition and downregulated in differentiated cells.
Poursani EM; Mehravar M; Soltani BM; Mowla SJ
Tumour Biol; 2017 Oct; 39(10):1010428317724280. PubMed ID: 29022482
[TBL] [Abstract][Full Text] [Related]
11. Expression and differentiation between OCT4A and its Pseudogenes in human ESCs and differentiated adult somatic cells.
Jez M; Ambady S; Kashpur O; Grella A; Malcuit C; Vilner L; Rozman P; Dominko T
PLoS One; 2014; 9(2):e89546. PubMed ID: 24586860
[TBL] [Abstract][Full Text] [Related]
12. Characterization of novel alternative splicing variants of Oct4 gene expressed in mouse pluripotent stem cells.
Liu X; Yu T; Sun Y; Wang H
J Cell Physiol; 2018 Jul; 233(7):5468-5477. PubMed ID: 29266259
[TBL] [Abstract][Full Text] [Related]
13. Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance.
Gwak JM; Kim M; Kim HJ; Jang MH; Park SY
Oncotarget; 2017 May; 8(22):36305-36318. PubMed ID: 28422735
[TBL] [Abstract][Full Text] [Related]
14. OCT4B1, a novel spliced variant of OCT4, is highly expressed in gastric cancer and acts as an antiapoptotic factor.
Asadi MH; Mowla SJ; Fathi F; Aleyasin A; Asadzadeh J; Atlasi Y
Int J Cancer; 2011 Jun; 128(11):2645-52. PubMed ID: 20824712
[TBL] [Abstract][Full Text] [Related]
15. The novel function of OCT4B isoform-265 in genotoxic stress.
Gao Y; Wei J; Han J; Wang X; Su G; Zhao Y; Chen B; Xiao Z; Cao J; Dai J
Stem Cells; 2012 Apr; 30(4):665-72. PubMed ID: 22247013
[TBL] [Abstract][Full Text] [Related]
16. Enhanced human somatic cell reprogramming efficiency by fusion of the MYC transactivation domain and OCT4.
Wang L; Huang D; Huang C; Yin Y; Vali K; Zhang M; Tang Y
Stem Cell Res; 2017 Dec; 25():88-97. PubMed ID: 29125994
[TBL] [Abstract][Full Text] [Related]
17. OCT4B modulates OCT4A expression as ceRNA in tumor cells.
Li D; Yang ZK; Bu JY; Xu CY; Sun H; Tang JB; Lin P; Cheng W; Huang N; Cui RJ; Yu XG; Zheng XL
Oncol Rep; 2015 May; 33(5):2622-30. PubMed ID: 25812694
[TBL] [Abstract][Full Text] [Related]
18. The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells.
Heng JC; Feng B; Han J; Jiang J; Kraus P; Ng JH; Orlov YL; Huss M; Yang L; Lufkin T; Lim B; Ng HH
Cell Stem Cell; 2010 Feb; 6(2):167-74. PubMed ID: 20096661
[TBL] [Abstract][Full Text] [Related]
19. Conclusive Evidence for OCT4 Transcription in Human Cancer Cell Lines: Possible Role of a Small OCT4-Positive Cancer Cell Population.
Miyamoto T; Mizuno N; Kosaka M; Fujitani Y; Ohno E; Ohtsuka A
Stem Cells; 2018 Sep; 36(9):1341-1354. PubMed ID: 29770522
[TBL] [Abstract][Full Text] [Related]
20. OCT4B Isoform Promotes Anchorage-Independent Growth of Glioblastoma Cells.
Choi SH; Kim JK; Jeon HY; Eun K; Kim H
Mol Cells; 2019 Feb; 42(2):135-142. PubMed ID: 30622231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]